Innate immunological pathways in COVID-19 pathogenesis

SR Paludan, TH Mogensen - Science immunology, 2022 - science.org
… In this review, we discuss current knowledge of the innate immunological pathways driving
host defense and pathological inflammation in the lungs of patients with critical COVID-19, …

Type I interferons in COVID-19 pathogenesis

E Palermo, D Di Carlo, M Sgarbanti, J Hiscott - Biology, 2021 - mdpi.com
… Genetic screening of 659 patients with severe COVID-19 relative to 534 individuals with
asymptomatic or benign infection revealed an enrichment in functional defective variants at the …

Pathogenesis and Management of COVID-19

KO Alfarouk, STS AlHoufie, SBM Ahmed… - Journal of …, 2021 - mdpi.com
COVID-19 patients means that any single, comprehensive approach to treatment is a dead-end
road. Further, our perceptions of COVID-19 … If patients are to be treated with new possible …

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

A Bonaventura, A Vecchié, L Dagna… - Nature Reviews …, 2021 - nature.com
… in patients with COVID-19 are lower than those reported in patients with non-COVID-19 ARDS,
… Through the analysis of lungs of patients who died from COVID-19-related ARDS, SARS-…

Virology, pathogenesis, diagnosis and in-line treatment of COVID-19

PK Samudrala, P Kumar, K Choudhary… - European journal of …, 2020 - Elsevier
… This report showed that 86% and 93% of the patients had COVID 19 negative results by day
7 in Hydroxychloroquine treated group and control group, respectively (Chen et al., 2020a). …

[HTML][HTML] Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning

Y Shoenfeld - Autoimmunity reviews, 2020 - ncbi.nlm.nih.gov
… of the pathogenesis of the hyperferritinemic syndrome including the infection with Covid-19. …
enriched with anti COVID-19 antibodies extracted from the SERA of patients who recovered …

Neutrophil extracellular traps and by-products play a key role in COVID-19: pathogenesis, risk factors, and therapy

AR Thierry, B Roch - Journal of clinical medicine, 2020 - mdpi.com
COVID-19 pathogenesis. Furthermore, it appears to us likely that these patients possess
pathogenicCOVID-19 patients [87]. Those with the greatest risk of developing a serious form of …

Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence

S Rahman, MTV Montero, K Rowe… - Expert review of …, 2021 - Taylor & Francis
… to treat COVID-19 patients ‘only in hospitalized patients with COVID-… patients with COVID-19
convalescent plasma and reported that transfusion is safe in patients with COVID-19 and …

COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice

J Zheng, LYR Wong, K Li, AK Verma, ME Ortiz… - Nature, 2021 - nature.com
… Furthermore, we show that infusion of convalescent plasma from a recovered patient with
COVID-19 protected against lethal disease. Mice developed anosmia at early time points after …

[HTML][HTML] Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatment

M Adamczak, S Surma… - Advances in Clinical and …, 2022 - advances.umw.edu.pl
… -19) and is one of the most common extrapulmonary complications of this disease. … patients
who require mechanical ventilation. The pathogenesis of acute kidney injury in COVID-19 is …